Definium Therapeutics

About Definium Therapeutics

Definium Therapeutics is a biopharmaceutical company focused on developing psychedelic medicine to advance psychiatry and brain health. The company is pursuing therapies for anxiety, depression, and autism spectrum disorder by leveraging psychedelic compounds and neuroscience research, with a pipeline that includes DT120 and DT402. Headquartered in New York, Definium aims to deliver science-led, evidence-backed treatments and to redefine mental healthcare with transparent and responsible practices.